SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for DOCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 62.03M
December 31, 2025 59.86M
September 30, 2025 58.22M
June 30, 2025 48.80M
March 31, 2025 50.34M
December 31, 2024 52.08M
September 30, 2024 44.47M
June 30, 2024 44.50M
March 31, 2024 43.49M
December 31, 2023 44.60M
September 30, 2023 39.17M
June 30, 2023 43.70M
March 31, 2023 42.91M
December 31, 2022 42.73M
Date Value
September 30, 2022 37.77M
June 30, 2022 36.86M
March 31, 2022 36.54M
December 31, 2021 34.78M
September 30, 2021 29.99M
June 30, 2021 26.57M
March 31, 2021 23.29M
December 31, 2020 21.50M
September 30, 2020 56.56M
June 30, 2020 16.39M
March 31, 2020 13.28M
December 31, 2019 12.62M
September 30, 2019 10.65M
June 30, 2019 10.34M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
OptimizeRx Corp. 8.242M
American Well Corp. 25.45M
Veeva Systems, Inc. 0.00
Hims & Hers Health, Inc. 331.67M
Phreesia, Inc. 42.57M